NYSEAMERICAN:ASXC Asensus Surgical (ASXC) Stock Price, News & Analysis $0.35 +0.00 (+0.64%) (As of 08/21/2024) Add Compare Share Share Today's Range$0.35▼$0.3550-Day Range N/A52-Week Range$0.17▼$0.40Volume4.00 million shsAverage Volume2.03 million shsMarket Capitalization$94.74 millionP/E RatioN/ADividend YieldN/APrice Target$0.35 Stock AnalysisStock AnalysisAnalyst ForecastsChartEarningsHeadlinesInsider TradesOwnershipShort InterestStock AnalysisAnalyst ForecastsChartEarningsHeadlinesInsider TradesOwnershipShort Interest Get Asensus Surgical alerts: Email Address Asensus Surgical MarketRank™ Stock AnalysisAnalyst RatingHold2.00 Rating ScoreUpside/Downside0.6% Upside$0.35 Price TargetShort InterestN/ADividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.24) to ($0.13) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.00 out of 5 stars 1.0 Analyst's Opinion Consensus RatingAsensus Surgical has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 2 hold ratings, and no sell ratings.Amount of Analyst CoverageAsensus Surgical has received no research coverage in the past 90 days.Read more about Asensus Surgical's stock forecast and price target. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for ASXC. Previous Next 0.0 Dividend Strength Dividend YieldAsensus Surgical does not currently pay a dividend.Dividend GrowthAsensus Surgical does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for ASXC. Previous Next 0.0 News and Social Media Coverage Search InterestOnly 1 people have searched for ASXC on MarketBeat in the last 30 days. This is a decrease of -89% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Asensus Surgical insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 2.87% of the stock of Asensus Surgical is held by insiders.Percentage Held by InstitutionsOnly 9.35% of the stock of Asensus Surgical is held by institutions.Read more about Asensus Surgical's insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Asensus Surgical are expected to grow in the coming year, from ($0.24) to ($0.13) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Asensus Surgical is -1.12, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Asensus Surgical is -1.12, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAsensus Surgical has a P/B Ratio of 2.68. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Porter & CompanyWar on Elon Escalates… Elon Musk, the guy slated to become the world’s first trillionaire by 2027, has publicly called for the adoption of this technology for decades. By doing so he has put himself in the crosshairs of an ideological war with the global elites. And yet, while this new technology threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.Click here to learn how you can benefit from its widespread distribution. About Asensus Surgical Stock (NYSEAMERICAN:ASXC)Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, the Middle East, Africa, and Asia. It digitizes the interface between the surgeon and the patient to perform performance-guided surgery for surgeons to deliver outcomes to patients. The company's products include Senhance System, a multi-port robotic surgery system that allows up to four arms to control robotic instruments and a camera for laparoscopic procedures; instruments and other products, including 3mm diameter instruments, 3mm and 5mm hooks, and articulating instruments; and Senhance ultrasonic system, an advanced energy device to deliver controlled energy to ligate and divide tissue. The company was formerly known as TransEnterix, Inc. and changed its name to Asensus Surgical, Inc. in February 2021. Asensus Surgical, Inc. is headquartered in Durham, North Carolina.Read More ASXC Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ASXC Stock News HeadlinesAugust 22, 2024 | globenewswire.comAsensus Surgical Announces Closing of Acquisition by KARL STORZAugust 21, 2024 | bizjournals.comDurham public company staves off potential bankruptcy, will be acquiredSeptember 16, 2024 | Porter & Company (Ad)War on Elon Escalates… Elon Musk, the guy slated to become the world’s first trillionaire by 2027, has publicly called for the adoption of this technology for decades. By doing so he has put himself in the crosshairs of an ideological war with the global elites. And yet, while this new technology threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.August 15, 2024 | bizjournals.comDurham company could face bankruptcy if $95M sale failsAugust 14, 2024 | msn.comBiggest stock movers today: NU, K, and moreAugust 13, 2024 | msn.comAsensus says it expects to file for bankruptcy if merger vote failsAugust 13, 2024 | seekingalpha.comAsensus Surgical, Inc. (ASXC) Q2 2024 Earnings Call TranscriptAugust 13, 2024 | finance.yahoo.comAsensus Surgical, Inc. Reports Operating and Financial Results for the Second Quarter 2024September 16, 2024 | Porter & Company (Ad)War on Elon Escalates… Elon Musk, the guy slated to become the world’s first trillionaire by 2027, has publicly called for the adoption of this technology for decades. By doing so he has put himself in the crosshairs of an ideological war with the global elites. And yet, while this new technology threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.August 13, 2024 | markets.businessinsider.comAsensus Surgical is about to announce earnings — here's what Wall Street expectsAugust 8, 2024 | uk.finance.yahoo.comMenhaden Resource Efficiency PLC - Net Asset Value(s)August 8, 2024 | globenewswire.comAsensus Surgical, Inc. Schedules Second Quarter Financial and Operating Results Conference Call for August 13, 2024August 7, 2024 | globenewswire.comAsensus Surgical 2024 Special Meeting of Stockholders Is AdjournedJuly 30, 2024 | globenewswire.comIndependent Proxy Advisory Firm ISS Recommends Asensus Surgical Stockholders Vote “FOR” the Pending Merger with KARL STORZJuly 29, 2024 | globenewswire.comGlass Lewis Recommends Asensus Surgical Stockholders Vote “FOR” Proposals Relating to Proposed Merger with KARL STORZJuly 27, 2024 | bloomberg.comAsensus Bridges Digital to Surgery: Vanguards of Health CareJuly 24, 2024 | globenewswire.comAsensus Surgical Announces The Rocky Mountain Hospital for Children in Denver, Colorado to Initiate Senhance Surgery ProgramJuly 23, 2024 | finanznachrichten.deAsensus Surgical, Inc.: Asensus Surgical Receives FDA 510(k) Clearance for Senhance Surgical System in UrologySee More Headlines Receive ASXC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Asensus Surgical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/13/2024Today9/16/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSEAMERICAN SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNYSEAMERICAN:ASXC CUSIPN/A CIKN/A Webwww.asensus.com Phone(919) 765-8400Fax919-765-8459Employees170Year FoundedN/APrice Target and Rating Average Stock Price Target$0.35 High Stock Price Target$0.35 Low Stock Price Target$0.35 Potential Upside/Downside+0.6%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($0.31) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-78,430,000.00 Net Margins-902.25% Pretax Margin-899.16% Return on Equity-184.10% Return on Assets-114.75% Debt Debt-to-Equity RatioN/A Current Ratio1.00 Quick Ratio0.69 Sales & Book Value Annual Sales$8.58 million Price / Sales11.04 Cash FlowN/A Price / Cash FlowN/A Book Value$0.13 per share Price / Book2.68Miscellaneous Outstanding Shares272,330,000Free Float264,516,000Market Cap$94.74 million OptionableNot Optionable Beta1.37 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Key ExecutivesMr. Anthony Fernando (Age 52)President, CEO & Director Comp: $901.03kMr. Shameze Rampertab B.Sc. MBA (Age 57)CA, CPA, Executive VP & CFO Comp: $511.25kMr. Joshua B. Weingard (Age 51)Chief Legal Officer & Secretary Mr. Paul Ziegler Jr. (Age 50)J.D., Vice President of Sales Mr. Ethan LoiselleVice President of Global MarketingMs. Amanda OwensVice President of PeopleMr. Ravi KommineniHead of Global Quality & RegulatoryMr. Motti FrimerVice President of R&D, Digital Solutions and MD of Asensus SurgicalMore ExecutivesKey CompetitorsNano-X ImagingNASDAQ:NNOXWestaimOTCMKTS:WEDXFClearPoint NeuroNASDAQ:CLPTTreace Medical ConceptsNASDAQ:TMCISight SciencesNASDAQ:SGHTView All CompetitorsInsidersWilliam N Starling JrBought 18,134 shares on 12/14/2023Total: $5,077.52 ($0.28/share)View All Insider Transactions ASXC Stock Analysis - Frequently Asked Questions How have ASXC shares performed this year? Asensus Surgical's stock was trading at $0.2466 at the beginning of 2024. Since then, ASXC shares have increased by 41.1% and is now trading at $0.3479. View the best growth stocks for 2024 here. How were Asensus Surgical's earnings last quarter? Asensus Surgical, Inc. (NYSEAMERICAN:ASXC) posted its earnings results on Tuesday, August, 13th. The company reported ($0.07) EPS for the quarter, missing the consensus estimate of ($0.05) by $0.02. The firm earned $2.21 million during the quarter, compared to the consensus estimate of $1.30 million. Asensus Surgical had a negative trailing twelve-month return on equity of 184.10% and a negative net margin of 902.25%. Who are Asensus Surgical's major shareholders? Top institutional investors of Asensus Surgical include Concourse Financial Group Securities Inc.. Insiders that own company stock include Andrea Biffi, William N Starling Jr, David Bruce Milne and Elizabeth Kwo. View institutional ownership trends. How do I buy shares of Asensus Surgical? Shares of ASXC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSEAMERICAN:ASXC) was last updated on 9/16/2024 by MarketBeat.com Staff From Our Partners44-year Wall Street Vet: “Permanent devastation is coming to America”After 44 years on Wall Street, I've seen it all... Black Monday, the Great Recession, the Covid crash. B...InvestorPlace | SponsoredBREAKING NEWS: AI Tech Now Used to Stop School ShootersTwo seconds. That's all it takes for Knightscope's Automated Gunshot Detection to notify authorities and map a...Market JAR | SponsoredMore Than 30 Federal Agencies Buy From This Cybersecurity TechIn January of 2022 Ukraine was hit by an especially nasty piece of malware, named WhisperGate. By then Ukra...Capital Trends | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredUnlock the Secret to Easy Wins with Iron CondorsDiscover the power of Iron Condor trades – a low-risk, high-reward strategy that allows you to profit consiste...Netpicks | SponsoredWhy Institutions Are Bullish on BitcoinThe recent dip in the crypto market might be stressful… But it also presents a tremendous opportunity for s...Crypto 101 Media | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredNvidia needs these 3 companies on a new $1 trillion SuperprojectNvidia is pivoting to a new $1 trillion Superproject that could revolutionize the AI industry… again. And i...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Asensus Surgical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Asensus Surgical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.